SPL
AVBP icon

Superior Planning, LLC’s ArriVent BioPharma AVBP Stock Holding History

Superior Planning, LLC’s Portfolio AVBP Stock Details AVBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.24K Buy
+173
New +$5.3K ﹤0.01% 1188

Other funds holding AVBP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Superior Planning, LLC's AVBP Position: Q3 2026 in Review

Superior Planning, LLC opened a new position in ArriVent BioPharma (AVBP) in Q3 2026: 173 shares worth $5.24K. The stake represents ﹤0.01% of the portfolio and ranks #1188 among its holdings.

68 funds tracked by Wall St. Rank hold AVBP as of Q3 2026.

  • Superior Planning, LLC held 173 shares of ArriVent BioPharma worth $5.24K as of Q3 2026.
  • ArriVent BioPharma was a new Superior Planning, LLC position in Q3 2026.
  • ArriVent BioPharma made up ﹤0.01% of Superior Planning, LLC's portfolio in Q3 2026, its #1188 holding.
  • 68 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q3 2026.

Based on Superior Planning, LLC's 13F filing for Q3 2026, filed 12 Nov 2026.